In lung cancer, the combination of cfDNA analysis and CTCs for EGFR mutation evaluation using VTX-1 liquid biopsy system (Vortex Biosciences) has enabled the analysis of EGFR mutations in both CTCs and cfDNA from a single blood collection [20, 21]. This evidence concerns the gene EGFR and lung carcinoma.